What we do
PET‑CT is essential to modern cancer pathways and specialist diagnostics, enabling earlier detection, accurate staging and informed treatment decisions.
Alliance Medical Group delivers PET‑CT services designed for specialist clinical use, combining advanced imaging, radiopharmaceutical integration and time‑critical service delivery.
Alliance Medical Group operates PET‑CT services through fixed diagnostic locations and flexible delivery models, ensuring access to molecular imaging where and when it is needed.
Services are integrated into existing diagnostic pathways and supported by specialist clinical teams, regulated operating frameworks and coordinated radiopharmaceutical supply. This enables PET‑CT imaging to function as a dependable component of complex diagnostic services rather than a standalone intervention.
PET‑CT supports cancer diagnosis, staging and assessment of treatment response by combining functional and anatomical imaging. This enables clinicians to make informed decisions where disease complexity requires greater diagnostic clarity.
In neurological diagnostics, PET‑CT supports assessment of conditions where metabolic or functional imaging provides insight beyond structural scans, contributing to diagnosis and disease evaluation.
PET‑CT supports specialist cardiac pathways by enabling evaluation of myocardial viability and function, informing diagnosis and ongoing management decisions.
Alliance Medical Group delivers PET‑CT services through three delivery models. These delivery models ensure PET‑CT services remain accessible, coordinated and responsive to clinical demand.
Supporting specialist referral pathways and routine diagnostic activity
PET‑CT delivered within Community Diagnostic Centre environments, where advanced imaging is provided outside acute hospital settings
Mobile PET‑CT services extending access where fixed infrastructure is unavailable or additional capacity is required
PET‑CT services delivered by Alliance Medical Group are underpinned by:
Specialist PET‑CT clinical, technical and operational teams
Integration with radiopharmaceutical production and tracer coordination
Regulated service delivery aligned to strict clinical and reporting timelines
This foundation ensures PET‑CT services operate consistently across diverse healthcare settings.
Delivering diagnostics
and insight at scale
